Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 1/2018

07.11.2017 | Case Report

Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance

verfasst von: Kumi Ozaki, Kenichi Harada, Toru Yamamoto, Hiroyuki Aoyagi, Yasuharu Kaizaki, Jun Yoshikawa

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The patient was a 43-year-old woman with obesity (body mass index: 29.1) and glucose intolerance who was not taking oral contraceptives. An ultrasound showed a hypoechoic hepatic mass. Dynamic contrast-enhanced computed tomography revealed a lesion in segment 6 that showed homogeneous and slight-to-moderate enhancement in the arterial phase with persistent enhancement during the portal and equilibrium phases. On magnetic resonance (MR) imaging, the lesion demonstrated hyperintensity on T2- and diffusion-weighted images and hypointensity in the hepatobiliary phase of gadoxetic-acid-enhanced MR imaging. In addition to the main lesion, approximately ten small hypointense lesions were seen in the hepatobiliary phase. The background liver was fatty without the deformity of chronic liver disease. Based on the pathological findings of the main lesion biopsy, it was initially suspected to be a non-neoplastic lesion with hematoxylin and eosin staining and initial immunohistochemical staining. However, the radiological findings indicated a neoplastic lesion. Additional immunohistochemical staining, including that for α-smooth muscle actin and organic anion transporter polypeptide 1B3, in combination with the radiological findings resulted in a diagnosis of unclassified hepatocellular adenoma. The other small lesions were presumed to be related to the main lesion.
Literatur
1.
Zurück zum Zitat Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–24.CrossRefPubMed Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–24.CrossRefPubMed
2.
Zurück zum Zitat Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50:481–9.CrossRefPubMed Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50:481–9.CrossRefPubMed
3.
Zurück zum Zitat Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.CrossRefPubMed Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.CrossRefPubMed
4.
Zurück zum Zitat Katabathina VS, Menias CO, Shanbhogue AKP, et al. Genetics and imaging of hepatocellular adenomas: 2011 update. RadioGraphics. 2011;31:1529–43.CrossRefPubMed Katabathina VS, Menias CO, Shanbhogue AKP, et al. Genetics and imaging of hepatocellular adenomas: 2011 update. RadioGraphics. 2011;31:1529–43.CrossRefPubMed
5.
Zurück zum Zitat Tse JR, Naini BV, Lu DS, et al. Qualitative and quantitative gadoxetic acid-enhanced MR imaging helps subtype hepatocellular adenomas. Radiology. 2016;279:118–27.CrossRefPubMed Tse JR, Naini BV, Lu DS, et al. Qualitative and quantitative gadoxetic acid-enhanced MR imaging helps subtype hepatocellular adenomas. Radiology. 2016;279:118–27.CrossRefPubMed
6.
Zurück zum Zitat Ba-Ssalamah A, Antunes C, Feier D, et al. Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Rdiology. 2015;277:104–13. Ba-Ssalamah A, Antunes C, Feier D, et al. Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Rdiology. 2015;277:104–13.
7.
Zurück zum Zitat Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012;262:520–9.CrossRefPubMed Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012;262:520–9.CrossRefPubMed
8.
Zurück zum Zitat van Aalten SM, Thomeer MG, Terkivatan T, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261:172–81.CrossRefPubMed van Aalten SM, Thomeer MG, Terkivatan T, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261:172–81.CrossRefPubMed
9.
Zurück zum Zitat Sasaki M, Yoneda N, Kitamura S, et al. Characterization of hepatocellular adenoma based on the phenotypic classification: the Kanazawa experience. Hepatol Res. 2011;41:982–8.CrossRefPubMed Sasaki M, Yoneda N, Kitamura S, et al. Characterization of hepatocellular adenoma based on the phenotypic classification: the Kanazawa experience. Hepatol Res. 2011;41:982–8.CrossRefPubMed
10.
Zurück zum Zitat Fukusato T, Soejima Y, Kondo F, et al. Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. Hepatol Res. 2015;45:E32–42.CrossRefPubMed Fukusato T, Soejima Y, Kondo F, et al. Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. Hepatol Res. 2015;45:E32–42.CrossRefPubMed
11.
Zurück zum Zitat Bambha K, Nagorney D, Sanderson S, et al. Hepatic adenomatosis in a young woman with glucose intolerance. Nat Clin Pract Gastroenterol Hepatol. 2006;3:526–31.CrossRefPubMed Bambha K, Nagorney D, Sanderson S, et al. Hepatic adenomatosis in a young woman with glucose intolerance. Nat Clin Pract Gastroenterol Hepatol. 2006;3:526–31.CrossRefPubMed
12.
Zurück zum Zitat Yoneda N, Matsui O, Kitao A, et al. Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol. 2012;30:777–82.CrossRefPubMed Yoneda N, Matsui O, Kitao A, et al. Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol. 2012;30:777–82.CrossRefPubMed
13.
Zurück zum Zitat Lagana SM, Salomao M, Bao F, et al. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. Appl Immunohistochem Mol Morphol. 2013;21:170–6.PubMed Lagana SM, Salomao M, Bao F, et al. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. Appl Immunohistochem Mol Morphol. 2013;21:170–6.PubMed
14.
Zurück zum Zitat Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol. 2011;21:2056–66.CrossRefPubMed Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol. 2011;21:2056–66.CrossRefPubMed
15.
Zurück zum Zitat Kitao A, Zen Y, Matsui O, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging–correlation with molecular transporters and histopathologic features. Radiology. 2010;256:817–26.CrossRefPubMed Kitao A, Zen Y, Matsui O, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging–correlation with molecular transporters and histopathologic features. Radiology. 2010;256:817–26.CrossRefPubMed
16.
Zurück zum Zitat Yoneda N, Matsui O, Kitao A, et al. Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol. 2012;30:499–508.CrossRefPubMed Yoneda N, Matsui O, Kitao A, et al. Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol. 2012;30:499–508.CrossRefPubMed
Metadaten
Titel
Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance
verfasst von
Kumi Ozaki
Kenichi Harada
Toru Yamamoto
Hiroyuki Aoyagi
Yasuharu Kaizaki
Jun Yoshikawa
Publikationsdatum
07.11.2017
Verlag
Springer Japan
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 1/2018
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-017-0788-2

Weitere Artikel der Ausgabe 1/2018

Clinical Journal of Gastroenterology 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.